ReviewTranslational andrology and urology2026
Sperm DNA fragmentation and its impact on pregnancy outcomes: a narrative review focusing on threshold definition and clinical strategies.
Review in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Sperm DNA fragmentation (SDF) is a key functional indicator for evaluating male fertility and the integrity of genetic material. However, a unified intervention threshold for SDF remains lacking, primarily due to variations in detection methodologies and significant heterogeneity across studies. This narrative review aims to summarize the association between SDF and pregnancy outcomes, with a focus on threshold definition and the influence of different detection methods and clinical scenarios. Methods: A comprehensive literature search was conducted in PubMed and Scopus databases from January 1990 to December 2023. Search terms included "sperm DNA fragmentation", "DFI", "SDF", "male infertility", "assisted reproductive technology", "pregnancy outcome", and "recurrent pregnancy loss". Studies evaluating the association between SDF and reproductive outcomes, as well as those reporting on diagnostic or prognostic thresholds, were considered for inclusion. Key Content and Findings: High SDF is significantly associated with lower fertilization rates and fewer high-quality embryos in assisted reproductive technology (ART), as well as an increased risk of recurrent pregnancy loss (RPL). Its clinical impact varies by mode of conception: it negatively affects natural pregnancy and intrauterine insemination (IUI), whereas in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), its effect on fertilization rate is less pronounced, but it may impair subsequent embryo development, reducing blastocyst formation rate and increasing miscarriage rate. The use of testicular sperm for ICSI in men with elevated SDF has been reported in observational studies, with some showing improved pregnancy and live birth rates. A 30% DNA fragmentation index (DFI) [sperm chromatin structure assay (SCSA)/terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)] is the most frequently referenced threshold, but reported cut offs vary from 10% to 36% depending on assay and outcome. Regarding detection technology, the SCSA is frequently described as the most extensively validated method, while the integration of novel technologies such as artificial intelligence offers the potential for more precise and efficient assessment in the future. Conclusions: SDF should be considered an important supplement to conventional semen analysis, especially in cases of unexplained infertility, ART failure, and RPL. This review emphasizes the necessity of establishing a unified clinical threshold, and current evidence highlights the need to standardize testing protocols, establish evidence-based SDF thresholds, and develop individualized management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.